Find in Library

Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy

oleh: Yuling Zhou, MS, Liang Zeng, MS, Nong Yang, MS, Yongchang Zhang, MD